Amantadine is used in two main clinical contexts: as an antiviral agent against influenza A and as a symptomatic treatment in Parkinson’s disease and certain drug-induced movement disorders. In influenza A, amantadine can reduce viral replication if started early in the course of illness, and has historically been used for both treatment and prophylaxis. Its antiviral role has diminished with rising resistance, so current use depends on circulating strains and susceptibility patterns.
In neurology, amantadine is valued for its dopaminergic and antiglutamatergic effects, which can improve bradykinesia, rigidity, and tremor in Parkinson’s disease and reduce dyskinesias related to long-term levodopa therapy. It is also prescribed for extrapyramidal symptoms caused by certain psychiatric medications. Decisions to use amantadine should consider patient age, renal function, psychiatric history, and concomitant medications.
Typical adult dosing for Parkinson’s disease and drug-induced extrapyramidal symptoms is 100 mg orally once or twice daily. Some patients may tolerate and benefit from titration to 100 mg two or three times daily, but doses above 300–400 mg per day are generally avoided due to increased risk of adverse effects. For treatment or prophylaxis of influenza A in adults, common regimens are 100 mg twice daily (total 200 mg/day); pediatric dosing is weight-based and must follow pediatric guidelines.
Because amantadine is renally excreted, dose adjustments are essential in renal impairment. For patients with creatinine clearance below 30 mL/min, dosing intervals should be extended or doses reduced; in severe renal failure or dialysis patients, individualized dosing and monitoring are required. Take amantadine with or without food at the same times each day to maintain consistent blood levels. Always follow prescriber instructions and, if obtained through telehealth services, complete any required clinical screening prior to shipment.
Before starting amantadine, assess renal function, psychiatric history, and cardiovascular status. Amantadine can cause central nervous system effects including confusion, hallucinations, and agitation—risks that increase in older adults and in patients with a history of psychosis. Use caution in those with seizure disorders, as amantadine may lower the seizure threshold.
Monitor for peripheral edema, orthostatic hypotension, and signs of cardiac arrhythmia. Adjust dosing in elderly patients and those with impaired renal function. If psychiatric symptoms emerge or worsen—new hallucinations, severe mood changes, suicidal ideation—discontinue amantadine and seek urgent medical evaluation. Pregnant and breastfeeding individuals should consult their clinician because data are limited and benefits must be weighed against potential risks.
Amantadine is contraindicated in patients with a known hypersensitivity to amantadine or any formulation excipients. Use is generally avoided in severe renal impairment unless careful dose adjustment and monitoring are available. Caution is warranted in patients with a history of severe psychiatric disorder or suicidal behavior; in such cases, alternative therapies may be preferred.
Where influenza A strains are known to be resistant to amantadine, antiviral use is not recommended. Check current public health guidance and resistance patterns before using amantadine for influenza treatment or prophylaxis. Always disclose all medical conditions and medications to the prescriber or telehealth clinician before initiating amantadine.
Common side effects include dizziness, insomnia, lightheadedness, nausea, dry mouth, and constipation. These effects are often dose-related and may improve with dose reduction. Patients may experience decreased appetite or mild peripheral edema. Because of its dopaminergic activity, amantadine can cause vivid dreams and sleep disturbances.
Serious but less common adverse reactions include confusion, hallucinations, psychosis, orthostatic hypotension, severe agitation, and livedo reticularis—a mottled cutaneous discoloration that can occur with prolonged use. Seizures have been reported, particularly in patients with a seizure history or with concomitant medications that lower the seizure threshold. Promptly report severe or unusual symptoms to a healthcare provider.
Amantadine interacts with several drug classes. Concurrent use with other central nervous system stimulants, anticholinergic agents, or dopamine agonists may amplify side effects such as hallucinations, confusion, or urinary retention. When combined with levodopa or dopamine agonists, amantadine can enhance antiparkinsonian effects but may also increase dyskinesia or neuropsychiatric adverse events.
Drugs that affect renal function or urinary pH may alter amantadine clearance—agents that reduce renal clearance can raise amantadine levels and toxicity risk. Use caution with tricyclic antidepressants, antipsychotics, and other medications that lower seizure threshold. Always provide a full medication list to your prescriber or pharmacist to evaluate potential interactions before starting therapy.
Another practical option is to explore Coreg while considering individual treatment needs.If you miss a dose of amantadine, take it as soon as you remember unless it is nearly time for your next scheduled dose. Do not double up to make up for a missed dose, as this increases the risk of side effects. Maintain a consistent dosing schedule to minimize fluctuations in symptom control and reduce adverse effects. If you frequently miss doses, discuss pill organizers, alarms, or other adherence strategies with your healthcare provider.
Symptoms of amantadine overdose may include severe CNS depression or excitation (confusion, coma, hallucinations), agitation, seizures, rapid heart rate, low blood pressure, and gastrointestinal distress. In cases of suspected overdose, seek emergency medical care immediately. Supportive care is the mainstay of treatment—maintain airway, breathing, and circulation; control seizures with benzodiazepines; and monitor cardiovascular and renal function closely.
Because amantadine is primarily renally excreted and is not highly protein-bound, hemodialysis can be effective for significant overdose and in patients with renal failure. Activated charcoal may be administered if the patient presents within an hour of ingestion and has an intact airway. Document all medications and amounts taken to assist emergency clinicians in management.
Store amantadine tablets or capsules at room temperature, ideally between 20°C and 25°C (68°F–77°F), protected from excessive heat, moisture, and light. Keep the medication in its original container with the label intact to preserve dosing information and expiration date. Do not use beyond the expiration date and avoid exposing tablets to extreme temperatures.
Keep all medications out of reach of children and pets. Dispose of unused or expired amantadine according to local medication disposal guidelines—many communities offer take-back programs or specific disposal instructions. If no take-back option exists, follow local waste disposal regulations and avoid flushing medications down the toilet unless indicated.
In the United States, amantadine is a prescription medication; however, Sunshine Pharmacy provides a lawful, structured pathway to obtain amantadine without an in-person prescription visit. Through telehealth consultations, clinician review, and pharmacist oversight—where permitted by state regulations—Sunshine Pharmacy evaluates patient eligibility, reviews medical history, and issues prescriptions as clinically appropriate. This model streamlines access while maintaining safety checks and compliance with applicable laws.
When using services that facilitate medication access online, ensure you complete required medical screening questionnaires and provide accurate health information. Sunshine Pharmacy emphasizes secure transactions, privacy protection, and adherence to state-specific prescribing requirements. If your state does not allow online prescribing for a particular indication, the pharmacy will advise on alternative lawful options and coordinate care with local providers as needed.
Important safety points: do not drive or operate heavy machinery until you know how amantadine affects you, as dizziness, drowsiness, and blurred vision can occur. Report any new or worsening psychiatric symptoms immediately. Inform your prescriber of pregnancy, breastfeeding status, or plans to conceive, since the risks and benefits must be weighed carefully.
Notify your healthcare team about all prescription and over-the-counter medications, supplements, and recreational substances. Regular monitoring of renal function is recommended, especially in older adults, to guide dosing. Avoid abrupt discontinuation after long-term use without medical advice; sudden stopping may exacerbate symptoms. Always follow dosing instructions and consult a clinician before making changes.
As a patient prescribed amantadine, understand your indication, the expected benefits, and potential side effects. Keep a symptom diary to track effectiveness for motor symptoms or reduction in dyskinesia, and note any cognitive or mood changes. Discuss vaccination status and influenza risk with your healthcare provider; amantadine is not a substitute for vaccination against influenza.
If you obtain amantadine through an online pharmacy like Sunshine Pharmacy, ensure you complete any required telemedicine evaluation honestly and keep copies of prescriptions and consultation notes. For any unexpected reactions or concerns—severe dizziness, suicidal thoughts, hallucinations, or signs of allergic reaction—stop the medication and seek urgent medical care. Regular follow-up with your clinician supports safe, effective use of amantadine and timely dose adjustments when needed.
Amantadine is a medication with antiviral and antiparkinsonian properties. It’s used in neurology to help reduce motor symptoms and levodopa-induced dyskinesia in Parkinson’s disease, and historically was used against influenza A; today its primary role is in Parkinson’s management rather than routine flu treatment.
Amantadine has several actions: it increases dopaminergic activity by promoting dopamine release and reducing reuptake, and it blocks NMDA-type glutamate receptors, which may help reduce dyskinesias and excitotoxicity. As an antiviral, it blocks the M2 ion channel of certain influenza A viruses to inhibit viral uncoating.
Common side effects include dizziness, lightheadedness, insomnia, dry mouth, nausea, constipation, peripheral edema, and livedo reticularis (a mottled skin discoloration). CNS effects such as hallucinations, confusion, or agitation can occur, especially at higher doses or in older adults.
Yes. Serious concerns include severe neuropsychiatric symptoms (psychosis, suicidal ideation), worsened heart failure or peripheral edema, seizures, and severe anticholinergic-like effects in susceptible people. It requires caution in patients with significant renal impairment, a history of psychosis, or cardiac disease.
Amantadine is available orally as immediate-release tablets, extended-release capsules, and syrup. It’s typically taken once or twice daily depending on formulation; extended-release forms allow once-daily dosing. Specific dosing and schedule should be determined by a clinician and adjusted for kidney function.
Yes. Because amantadine is primarily eliminated by the kidneys, impaired renal function increases drug levels and risk of toxicity. Dose adjustments or alternative therapies are often required for patients with reduced renal clearance.
Some symptomatic benefit — especially for dyskinesia and certain motor symptoms — can be noticed within days to a few weeks, but full effects may take several weeks. Response varies between individuals and clinicians will reassess benefit and tolerability over time.
Amantadine was once used for influenza A prophylaxis and treatment, but many circulating influenza A strains are resistant to adamantanes. Because of widespread resistance, neuraminidase inhibitors (like oseltamivir) or other antivirals are generally preferred; current public health guidance should be followed.
Data are limited. Potential risks and benefits should be discussed with a clinician; generally, amantadine is used only if the potential benefit outweighs potential risks. Breastfeeding mothers should consult their healthcare provider because amantadine is excreted in breast milk.
Regular monitoring should include assessment of renal function, mental status (for hallucinations or mood changes), fluid status (for edema), and dermatologic changes (livedo reticularis). Periodic review of overall efficacy and side effects is important, especially in older adults.
Yes. Drugs that reduce dopaminergic activity (e.g., antipsychotics, metoclopramide) can blunt amantadine’s benefit. Concomitant medications that affect renal clearance or increase CNS stimulation can raise the risk of adverse effects. Always review all medications with a clinician or pharmacist.
Abrupt discontinuation can worsen Parkinsonian symptoms or cause a withdrawal-like exacerbation of motor issues and neuropsychiatric symptoms. Clinicians typically recommend tapering when stopping the drug to reduce the risk of sudden deterioration.
It can be used but with caution: older adults are more susceptible to cognitive and psychiatric side effects, orthostatic hypotension, and reduced renal clearance. Lower starting doses, careful monitoring, and frequent reassessment are recommended.
Amantadine has been studied off-label for conditions such as fatigue in multiple sclerosis, certain traumatic brain injury symptoms, and persistent post-concussive symptoms, with mixed evidence. Off-label use should be guided by specialist input and current evidence.
An overdose can cause severe CNS depression or excitation, seizures, cardiac disturbances, and other life-threatening effects. Seek immediate emergency medical care; treatment is supportive and may include activated charcoal and symptomatic management.
Both amantadine and rimantadine are adamantane antivirals that target influenza A M2 channels, but because most current influenza A strains are resistant to adamantanes, neither drug is generally recommended for routine influenza treatment. Resistance patterns and public health guidelines determine antiviral choice.
Although both have NMDA-antagonist activity, memantine is used primarily for moderate-to-severe Alzheimer’s disease and lacks significant dopaminergic-enhancing effects. Amantadine has notable dopaminergic activity useful in Parkinson’s disease and dyskinesia, making its clinical uses distinct.
Levodopa (often combined with carbidopa) is the most potent and reliable medication for cardinal Parkinson’s motor symptoms (bradykinesia, rigidity). Amantadine provides more modest symptomatic benefit and is especially useful as an adjunct for reducing levodopa-induced dyskinesia rather than replacing levodopa.
Dopamine agonists directly stimulate dopamine receptors and are effective for motor symptoms and motor fluctuation management but carry risks like impulse control disorders and excessive daytime sleepiness. Amantadine works by increasing dopamine release and antagonizing NMDA receptors and is often used to target dyskinesia; side-effect profiles differ and choice depends on patient-specific factors.
MAO-B inhibitors slow dopamine breakdown and are commonly used for early symptomatic control and to extend levodopa benefit; they have their own interaction risks (e.g., hypertensive reactions with certain drugs). Amantadine’s role is more adjunctive for dyskinesia and certain motor symptoms. Selection is based on symptom profile, side-effect tolerance, and treatment goals.
Anticholinergics (e.g., trihexyphenidyl) can be effective for tremor, especially in younger patients, but have significant cognitive and peripheral anticholinergic side effects that limit use in older adults. Amantadine may modestly help tremor with a different side-effect spectrum and may be preferred in patients at higher risk of anticholinergic toxicity.
Yes. Amantadine is frequently used as an adjunct to carbidopa-levodopa to help manage dyskinesia and sometimes to smooth motor fluctuations. It does not replace levodopa’s core symptomatic benefit but can complement levodopa therapy.
COMT inhibitors extend levodopa’s half-life and help reduce "wearing-off" fluctuations, while amantadine is used primarily to reduce dyskinesia and may modestly improve motor function. The two classes can be complementary depending on whether the dominant problem is wearing-off or dyskinesia.
Oseltamivir and other neuraminidase inhibitors are preferred for influenza treatment today because many influenza A strains are resistant to adamantanes like amantadine. Neuraminidase inhibitors have broader activity (including influenza B) and more favorable resistance profiles based on current public health guidance.
Both can cause CNS and GI side effects, but specific tolerability varies between individuals. Because both are in the same adamantane class, their adverse-effect profiles are similar, and neither is widely used for influenza given resistance concerns; in Parkinson’s care, amantadine’s dopaminergic benefits make it the clinically relevant agent.
Dopamine precursors like levodopa typically provide faster and more robust relief of cardinal Parkinson’s symptoms than amantadine. Amantadine tends to offer more modest symptomatic improvement and is valued mainly for reducing dyskinesia and as an adjunctive agent.
Yes. Amantadine is often preferred when levodopa-induced dyskinesias are prominent, when a patient cannot tolerate certain dopamine agonists or anticholinergics, or when clinicians seek a medication with both dopaminergic and NMDA-antagonist actions. Individual factors—age, comorbidities, renal function, and neuropsychiatric history—guide the choice.
Treatment selection should be individualized based on the dominant symptoms (e.g., tremor vs dyskinesia vs bradykinesia), patient age, cognitive status, renal function, comorbidities, and risk of specific side effects. Shared decision-making with a neurologist or movement-disorder specialist yields the best tailored approach.
